BASELINE HBSAG LEVELS PREDICT HBSAG LOSS IN HBEAG NEGATIVE BUT NOT IN HBEAG POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON ALFA-2A (PEGASYS®) AND ADEFOVIR (HEPSERA): AN INTERIM ANALYSIS

被引：0
|
作者：
Takkenberg, Bart [1 ,2 ]
Zaaijer, Hans L. [3 ,4 ]
de Niet, Annikki [1 ,2 ]
Weegink, Christine J. [1 ,2 ]
Terpstra, Valeska [5 ]
Koot, Maarten [7 ]
Dijkgraaf, Marcel [6 ]
Jansen, Peter L. [1 ,2 ]
Janssen, Harry L. [8 ]
Beld, Marcel [9 ]
Reesink, Hendrik W. [1 ,2 ]
机构：
[1] AMC Liver Ctr, Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Med Microbiol & Karl Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands
[4] Ctr Infect Dis & Immunol CINIMA, Amsterdam, Netherlands
[5] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands
[6] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands
[7] Sanquin, Dept Virus Diagnost Serv, Amsterdam, Netherlands
[8] Erasmus MC, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands
[9] KIT Biomed Res, Amsterdam, Netherlands
来源：
HEPATOLOGY | 2009年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
488
引用
收藏
页码：536A / 537A
页数：2
相关论文
共 50 条
  • [41] EARLY REDUCTION OF SERUM HBSAG LEVELS IN HBEAG-NEGATIVE CHRONIC HEPATITIS B PATIENTS ACHIEVING SUSTAINED VIROLOGICAL RESPONSE AFTER PEGINTERFERON ALFA-2A ± RIBAVIRIN TREATMENT
    Rijckborst, Vincent
    ter Borg, Martijn J.
    Akarca, Ulus S.
    Grima, Piero
    Flisiak, Robert
    Vafiadis-Zouboulis, Irini
    Tripi, Silvio
    van Doornum, Gerard J.
    Verhey, Elke
    van Vuuren, Anneke J.
    Hansen, Bettina E.
    Janssen, Harry L.
    HEPATOLOGY, 2008, 48 (04) : 749A - 750A
  • [42] New treatment strategy: switching from long-term entecavir to peginterferon alfa-2a induces HBeAg seroconversion/HBsAg clearance in patients with HBeAg-positive chronic hepatitis B
    Ning, Qin
    Han, Meifang
    Sun, Yongtao
    Jiang, Jia-ji
    Tan, Deming
    Hou, Jinlin
    Tang, Hong
    Sheng, Jifang
    Zhao, Mianzhi
    HEPATOLOGY, 2012, 56 : 300A - 301A
  • [43] Pretreatment HBsAg serum levels predict HBsAg seroconversion in HBeAg-negative chronic hepatitis B (CHBe-) patients
    Manesis, EK
    Hadziyannis, ES
    Angelopoulou, OP
    Hadziyannis, SJ
    HEPATOLOGY, 2005, 42 (04) : 590A - 590A
  • [44] EXTENDING PEGINTERFERON ALFA-2A THERAPY IN PATIENTS WITH HBEAG-POSITIVE CHRONIC HEPATITIS B WHO DID NOT ACHIEVE A RESPONSE AT WEEK 48 CAN LEAD TO HBEAG SEROCONVERSION AND HBSAG CLEARANCE
    Chen, Xiao P.
    Chen, Xue-Fu
    Huang, Ji
    Chen, Wen-Li
    Ren, Chen
    Ma, Xiao-jun
    Luo, X-d
    HEPATOLOGY, 2009, 50 (04) : 499A - 499A
  • [45] The baseline combination of HBcrAg and HBsAg titers enhance treatment outcome and HBsAg loss predictions in HBeAg negative chronic hepatitis B patients treated with pegylated interferon alfa-2a or PegIFN plus Tenofovir-disoproxil-fumarate
    Martinot-Peignoux, Michelle
    Lapalus, Martine
    Boyer, Nathalie
    Castelnau, Corinne
    Giuily, Nathalie
    Pouteau, Michele
    Moucari, Rami
    Asselah, Tarik
    Marcellin, Patrick
    HEPATOLOGY, 2015, 62 : 1205A - 1205A
  • [46] EFFICACY OF PEGINTERFERON ALFA-2A OR ALFA-2B IN TREATMENT OF HBEAG NEGATIVE CHRONIC HEPATITIS B INFECTION
    Karabay, Oguz
    Tuna, Nazan
    Esen, Saban
    HEPATOLOGY, 2011, 54 : 1061A - 1061A
  • [47] Changes of serum HBsAg levels in HBeAg-negative chronic hepatitis B patients treated with tenofovir
    Papatheodoridis, George V.
    Triantos, Christos K.
    Hadziyannis, Emilia
    Zisimopoulos, Konstantinos
    Georgiou, Anastasia
    Margariti, Katerina
    Deutsch, Melanie
    Nikolopoulou, Vasiliki
    Manolakopoulos, Spilios
    HEPATOLOGY, 2013, 58 : 686A - 687A
  • [48] Composition of HBsAg is predictive of HBsAg loss during treatment in patients with HBeAg-positive chronic hepatitis B
    Pfefferkorn, Maria
    Schott, Tina
    Boehm, Stephan
    Deichsel, Danilo
    Felkel, Christin
    Gerlich, Wolfram H.
    Glebe, Dieter
    Wat, Cynthia
    Pavlovic, Vedran
    Heyne, Renate
    Berg, Thomas
    van Boemmel, Florian
    JOURNAL OF HEPATOLOGY, 2021, 74 (02) : 283 - 292
  • [49] Comparison of Serum Hepatitis B Virus DNA and HBsAg Levels Between HBeAg-Negative and HBeAg-Positive Chronic Hepatitis B Patients
    Keshvari, Maryam
    Alavian, Seyed Moayed
    Sharafi, Heidar
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2015, 8 (03)
  • [50] Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B
    Piratvisuth, Teerha
    Lau, George
    Chao, You-Chen
    Jin, Rui
    Chutaputti, Anuchit
    Zhang, Q. -B.
    Tanwandee, Tawesak
    Button, Peter
    Popescu, Matei
    HEPATOLOGY INTERNATIONAL, 2008, 2 (01) : 102 - 110
12345